{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:58:30Z","timestamp":1790114310552,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T00:00:00Z","timestamp":1647302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Central diabetes insipidus (CDI) is a rare condition caused by various underlying diseases including inflammatory and autoimmune diseases, and neoplasms. Obtaining an accurate definitive diagnosis of the underlying cause of CDI is difficult. Recently, anti-rabphilin-3A antibodies were demonstrated to be a highly sensitive and specific marker of lymphocytic infundibuloneurohypophysitis (LINH). Here, we report a detailed case series, and evaluated the significance of anti-rabphilin-3A antibodies in differentiating the etiologies of CDI. A prospective analysis was conducted in 15 consecutive patients with CDI from 2013 to 2020 at a single referral center. Anti-rabphilin-3A antibodies were measured and the relationship between antibody positivity and the clinical\/histopathological diagnoses was evaluated. Among 15 CDI patients, the positive anti-rabphilin-3A antibodies were found in 4 of 5 LINH cases, 3 of 4 lymphocytic panhypophysitis (LPH) cases, one of 2 sarcoidosis cases, and one intracranial germinoma case, respectively. Two Rathke cleft cyst cases and one craniopharyngioma case were negative. This is the first report of anti-rabphilin-3A antibodies positivity in CDI patients with biopsy-proven LPH. Measurement of anti-rabphilin-3A antibodies may be valuable for differentiating CDI etiologies.<\/jats:p>","DOI":"10.1038\/s41598-022-08552-y","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T14:04:54Z","timestamp":1647353094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Studies on anti-rabphilin-3A antibodies in 15 consecutive patients presenting with central diabetes insipidus at a single referral center"],"prefix":"10.1038","volume":"12","author":[{"given":"Zenei","family":"Arihara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satsuki","family":"Niitsuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Inoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"8552_CR1","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1210\/jc.2013-4411","volume":"99","author":"KV Juul","year":"2014","unstructured":"Juul, K. V., Schroeder, M., Rittig, S. & N\u00f8rgaard, J. P. National surveillance of central diabetes insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients. J. Clin. Endocrinol. Metab. 99, 2181\u20132187 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"8552_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41572-019-0103-2","volume":"5","author":"M Christ-Crain","year":"2019","unstructured":"Christ-Crain, M. et al. Diabetes insipidus. Nat. Rev. Dis. Primers. 5, 54 (2019).","journal-title":"Nat. Rev. Dis. Primers."},{"key":"8552_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1159\/000336333","volume":"77","author":"N Di Iorgi","year":"2012","unstructured":"Di Iorgi, N. et al. Diabetes insipidus: diagnosis and management. Horm. Res. Paediatr. 77, 69\u201384 (2012).","journal-title":"Horm. Res. Paediatr."},{"key":"8552_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1210\/er.2004-0011","volume":"26","author":"P Caturegli","year":"2005","unstructured":"Caturegli, P. et al. Autoimmune hypophysitis. Endocr. Rev. 26, 599\u2013614 (2005).","journal-title":"Endocr. Rev."},{"key":"8552_CR5","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1056\/NEJM200010053431403","volume":"343","author":"M Maghnie","year":"2000","unstructured":"Maghnie, M. et al. Central diabetes insipidus in children and young adults. N. Engl. J. Med. 343, 998\u20131007 (2000).","journal-title":"N. Engl. J. Med."},{"key":"8552_CR6","doi-asserted-by":"publisher","first-page":"E1352","DOI":"10.1210\/jc.2011-0513","volume":"96","author":"I Marchand","year":"2011","unstructured":"Marchand, I. et al. Central diabetes inspidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents. J. Clin. Endocrinol. Matab. 96, E1352\u2013E1360 (2011).","journal-title":"J. Clin. Endocrinol. Matab."},{"key":"8552_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1507\/endocrj.EJ13-0368","volume":"61","author":"H Arima","year":"2014","unstructured":"Arima, H. et al. Adipsia increases risk of death in patients with central diabetes inspidus. Endocr. J. 61, 143\u2013148 (2014).","journal-title":"Endocr. J."},{"key":"8552_CR8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1210\/jc.2013-3724","volume":"99","author":"N Di Iorgi","year":"2014","unstructured":"Di Iorgi, N. et al. Central diabetes inspidus in children and young adults: etiological diagnosis and long-term outcome of idiopathic cases. J. Clin. Endocrinol. Metab. 99, 1264\u20131272 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"8552_CR9","doi-asserted-by":"publisher","first-page":"3825","DOI":"10.1210\/jcem.87.8.8757","volume":"87","author":"A De Bellis","year":"2002","unstructured":"De Bellis, A. et al. Longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidus. J. Clin. Endocrinol. Metab. 87, 3825\u20133829 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"8552_CR10","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1210\/jc.2002-020791","volume":"88","author":"R Pivonello","year":"2003","unstructured":"Pivonello, R. et al. Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology. J. Clin. Endocrinol. Metab. 88, 1629\u20131636 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"8552_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1210\/jcem-31-4-391","volume":"31","author":"T Saito","year":"1970","unstructured":"Saito, T., Yoshida, S., Nakao, K. & Takanashi, R. Chronic hypernatremia associated with inflammation of the neurohypophysis. J. Clin. Endocrinol. Metab. 31, 391\u2013396 (1970).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"8552_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJM199309023291002","volume":"329","author":"H Imura","year":"1993","unstructured":"Imura, H. et al. Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. N. Engl. J. Med. 329, 683\u2013689 (1993).","journal-title":"N. Engl. J. Med."},{"key":"8552_CR13","first-page":"1399","volume":"113","author":"H Kojima","year":"1989","unstructured":"Kojima, H. et al. Diabetes insipidus caused by lymphocytic infundibuloneurohypophysitis. Arch. Pathol. Lab. Med. 113, 1399\u20131401 (1989).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"8552_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10014-008-0234-8","volume":"25","author":"T Abe","year":"2008","unstructured":"Abe, T. Lymphocytic infundibulo-neurohypophysitis and infundibulo-panhypophysitis regarded as lymphocytic hypophysitis variant. Brain Tumor Pathol. 25, 59\u201366 (2008).","journal-title":"Brain Tumor Pathol."},{"key":"8552_CR15","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s11102-016-0736-z","volume":"19","author":"G Bellastella","year":"2016","unstructured":"Bellastella, G. et al. Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects. Pituitary 19, 625\u2013642 (2016).","journal-title":"Pituitary"},{"key":"8552_CR16","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1530\/EJE-19-1051","volume":"182","author":"Y Takahashi","year":"2020","unstructured":"Takahashi, Y. MECHANISMS IN ENDOCRINOLOGY: Autoimmune hypopituitarism: novel mechanistic insights. Eur. J. Endocrinol. 182, R59\u2013R66 (2020).","journal-title":"Eur. J. Endocrinol."},{"key":"8552_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11102-006-6598-z","volume":"9","author":"JA Rivera","year":"2006","unstructured":"Rivera, J. A. Lymphocytic hypophysitis: disease spectrum and approach to diagnosis and therapy. Pituitary 9, 35\u201345 (2006).","journal-title":"Pituitary"},{"key":"8552_CR18","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.humpath.2007.06.011","volume":"38","author":"S Wong","year":"2007","unstructured":"Wong, S., Lam, W. Y., Wong, W. K. & Lee, K. C. Hypophysitis presented as inflammatory pseudotumor in immunoglobulin G4-related systemic disease. Hum. Pathol. 38, 1720\u20131723 (2007).","journal-title":"Hum. Pathol."},{"key":"8552_CR19","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1210\/jc.2010-2970","volume":"96","author":"P Leporati","year":"2011","unstructured":"Leporati, P., Landek-Salgado, M. A., Lupi, I., Chiovato, L. & Caturegli, P. IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J. Clin. Endocrinol. Metab. 96, 1971\u20131980 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"8552_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1530\/EJE-13-0642","volume":"170","author":"H Bando","year":"2014","unstructured":"Bando, H. et al. The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and\/or central diabetes insipidus and review of the literature. Eur. J. Endocrinol. 170, 161\u2013172 (2014).","journal-title":"Eur. J. Endocrinol."},{"key":"8552_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11102-016-0780-8","volume":"20","author":"N Iwata","year":"2017","unstructured":"Iwata, N. et al. Anti-pituitary antibodies against corticotrophs in IgG4-related hypophysitis. Pituitary 20, 301\u2013310 (2017).","journal-title":"Pituitary"},{"key":"8552_CR22","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1507\/endocrj.K09E-277","volume":"56","author":"A Shimatsu","year":"2009","unstructured":"Shimatsu, A., Oki, Y., Fujisawa, I. & Sano, T. Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr. J. 56, 1033\u20131041 (2009).","journal-title":"Endocr. J."},{"key":"8552_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1474-4422(17)30471-4","volume":"17","author":"MA AbdelRazek","year":"2018","unstructured":"AbdelRazek, M. A., Venna, N. & Stone, J. H. IgG4-related disease of the central and peripheral nervous systems. Lancet Neurol. 17, 183\u2013192 (2018).","journal-title":"Lancet Neurol."},{"key":"8552_CR24","first-page":"1362","volume":"82","author":"SL Mootha","year":"1997","unstructured":"Mootha, S. L. et al. Idiopathic hypothalamic diabetes insipidus, pituitary stalk thickening, and the occult intracranial germinoma in children and adolescents. J. Clin. Endocrinol. Metab. 82, 1362\u20131367 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"8552_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/cen.12769","volume":"83","author":"N Di Iorgi","year":"2015","unstructured":"Di Iorgi, N., Morana, G. & Maghnie, M. Pituitary stalk thickening on MRI: when is the best time to re-scan and how long should we continue re-scanning for?. Clin. Endocrinol. (Oxf) 83, 449\u2013455 (2015).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"8552_CR26","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0140-6736(83)91328-4","volume":"1","author":"WA Scherbaum","year":"1983","unstructured":"Scherbaum, W. A. & Bottazzo, G. F. Autoantibodies to vasopressin cells in idiopathic diabetes insipidus: evidence for an autoimmune variant. Lancet 1, 897\u2013901 (1983).","journal-title":"Lancet"},{"key":"8552_CR27","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1365-2265.2006.02616.x","volume":"65","author":"M Maghnie","year":"2006","unstructured":"Maghnie, M. et al. Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin-cell antibodies and markers of autoimmunity. Clin. Endocrinol. (Oxf) 65, 470\u2013478 (2006).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"8552_CR28","doi-asserted-by":"publisher","first-page":"E946","DOI":"10.1210\/jc.2014-4209","volume":"100","author":"S Iwama","year":"2015","unstructured":"Iwama, S. et al. Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis. J. Clin. Endocrinol. Metab. 100, E946-954 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"8552_CR29","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1507\/endocrj.EJ19-0569","volume":"67","author":"H Takagi","year":"2020","unstructured":"Takagi, H. et al. Diagnosis and treatment of autoimmune and IgG4-related hypophysitis: clinical guidelines of the Japan Endocrine Society. Endocr. J. 67, 373\u2013378 (2020).","journal-title":"Endocr. J."},{"key":"8552_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2265.1995.tb01881.x","volume":"42","author":"JK Powrie","year":"1995","unstructured":"Powrie, J. K., Powell, M., Ayers, A. B., Lowy, C. & S\u00f6nksen, P. H. Lymphocytic adenohypophysitis: magnetic resonance imaging features of two new cases and a review of the literature. Clin. Endocrinol. (Oxf) 42, 315\u2013322 (1995).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"8552_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s002340050550","volume":"40","author":"S Saiwai","year":"1998","unstructured":"Saiwai, S. et al. Lymphocytic adenohypophysitis: skull radiographs and MRI. Neuroradiology 40, 114\u2013120 (1998).","journal-title":"Neuroradiology"},{"key":"8552_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/eje.1.02183","volume":"155","author":"A Gutenberg","year":"2006","unstructured":"Gutenberg, A. et al. Primary hypophysitis: clinical-pathological correlations. Eur. J. Endocrinol. 155, 101\u2013107 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"8552_CR33","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4137\/JCM.S6254","volume":"2","author":"Y Wada","year":"2011","unstructured":"Wada, Y. et al. Lymphocytic panhypophysitis: its clinical features in Japanese cases. Jpn. Clin. Med. 2, 15\u201320 (2011).","journal-title":"Jpn. Clin. Med."},{"key":"8552_CR34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.7878\/jjsogd.35.3","volume":"35","author":"N Shijubo","year":"2015","unstructured":"Shijubo, N. & Yamaguchi, T. Diagnosis criteria and classification of disease severity for sarcoidosis in Japan. Jpn. J. Sarcoidosis Granulomatous Disord. 35, 3\u20138 (2015).","journal-title":"Jpn. J. Sarcoidosis Granulomatous Disord."},{"key":"8552_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1507\/endocrj.EJ17-0028","volume":"64","author":"K Sakurai","year":"2017","unstructured":"Sakurai, K. et al. Usefulness of anti-rabphilin-3A antibodies for diagnosing central diabetes insipidus in the third trimester of pregnancy. Endocr. J. 64, 645\u2013650 (2017).","journal-title":"Endocr. J."},{"key":"8552_CR36","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1210\/jc.2015-2152","volume":"100","author":"J Honegger","year":"2015","unstructured":"Honegger, J. et al. Diagnosis of Primary Hypophysitis in Germany. J. Clin. Endocrinol. Metab. 100, 3841\u20133849 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"8552_CR37","doi-asserted-by":"publisher","first-page":"101440","DOI":"10.1016\/j.beem.2020.101440","volume":"34","author":"G Patti","year":"2020","unstructured":"Patti, G. et al. Central diabetes insipidus in children: Diagnosis and management. Best Pract. Res. Clin. Endocrinol. Metab. 34, 101440 (2020).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"8552_CR38","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1210\/jcem.84.9.5945","volume":"84","author":"A De Bellis","year":"1999","unstructured":"De Bellis, A. et al. A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus. J. Clin. Endocrinol. Metab. 84, 3047\u20133051 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"8552_CR39","first-page":"375","volume":"68","author":"R Takeda","year":"2021","unstructured":"Takeda, R. et al. Pregnancy-associated diabetes inspidus in Japan: a review based on quoting from the literatures reported during the period from 1982 to 2019. Encocr. J. 68, 375\u2013385 (2021).","journal-title":"Encocr. J."},{"key":"8552_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1297\/cpe.30.65","volume":"30","author":"Y Kume","year":"2021","unstructured":"Kume, Y. et al. Lymphocytic infundibuloneurohypophysitis with positive anti-rabphilin-3A antibodies nine years post-onset of central diabetes insipidus. Clin. Pediatr. Endocrinol. 30, 65\u201369 (2021).","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"8552_CR41","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1210\/jc.2012-2269","volume":"97","author":"A De Bellis","year":"2012","unstructured":"De Bellis, A. et al. Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. J. Clin. Endocrinol. Metab. 97, 3684\u20133690 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"8552_CR42","doi-asserted-by":"publisher","first-page":"e6034","DOI":"10.1097\/MD.0000000000006034","volume":"96","author":"K Shibue","year":"2017","unstructured":"Shibue, K. et al. Rapid exacerbation of lymphocytic infundibuloneurohypophysitis. Medicine (Baltimore) 96, e6034 (2017).","journal-title":"Medicine (Baltimore)"},{"key":"8552_CR43","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11102-009-0187-x","volume":"14","author":"A Gutenberg","year":"2011","unstructured":"Gutenberg, A. et al. Pituitary and systemic autoimmunity in a case of intrasellar germinoma. Pituitary 14, 388\u2013394 (2011).","journal-title":"Pituitary"},{"key":"8552_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fendo.2020.00016","volume":"11","author":"G Patti","year":"2020","unstructured":"Patti, G. et al. antibodies against hypothalamus and pituitary gland in childhood-onset brain tumors and pituitary dysfunction. Front. Endocrinol. (Lausanne) 11, 16 (2020).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"8552_CR45","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11102-011-0355-7","volume":"15","author":"F Guaraldi","year":"2012","unstructured":"Guaraldi, F., Caturegli, P. & Salvatori, R. Prevalence of antipituitary antibodies in acromegaly. Pituitary 15, 490\u2013494 (2012).","journal-title":"Pituitary"},{"key":"8552_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/nan.12570","volume":"46","author":"H Takami","year":"2020","unstructured":"Takami, H. et al. Intratumoural immune cell landscape in germinoma reveals multipotent lineages and exhibits prognostic significance. Neuropathol. Appl. Neurobiol. 46, 111\u2013124 (2020).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"8552_CR47","doi-asserted-by":"publisher","first-page":"10946","DOI":"10.1016\/S0021-9258(19)49857-8","volume":"267","author":"H Shirataki","year":"1992","unstructured":"Shirataki, H. et al. A possible target protein for smg-25A\/rab3A small GTP-binding protein. J. Biol. Chem. 267, 10946\u201310949 (1992).","journal-title":"J. Biol. Chem."},{"key":"8552_CR48","first-page":"2061","volume":"13","author":"H Shirataki","year":"1993","unstructured":"Shirataki, H. et al. Rabphilin-3A, a putative target protein for smg p25A\/rab3A p25 small GTP-binding protein related to synaptotagmin. Mol. Cell Biol. 13, 2061\u20132068 (1993).","journal-title":"Mol. Cell Biol."},{"key":"8552_CR49","doi-asserted-by":"publisher","first-page":"39253","DOI":"10.1074\/jbc.M507173200","volume":"280","author":"T Tsuboi","year":"2005","unstructured":"Tsuboi, T. & Fukuda, M. The C2B domain of rabphilin directly interacts with SNAP-25 and regulates the docking step of dense core vesicle exocytosis in PC12 cells. J. Biol. Chem. 280, 39253\u201339259 (2005).","journal-title":"J. Biol. Chem."},{"key":"8552_CR50","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1038\/sj.emboj.7601165","volume":"25","author":"F De\u00e1k","year":"2006","unstructured":"De\u00e1k, F. et al. Rabphilin regulates SNARE-dependent re-priming of synaptic vesicles for fusion. EMBO J. 25, 2856\u20132866 (2006).","journal-title":"EMBO J."},{"key":"8552_CR51","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1507\/endocrj.EJ17-0399","volume":"65","author":"K Nakashima","year":"2018","unstructured":"Nakashima, K. et al. Cullin-associated NEDD8-dissociated protein 1, a novel interactor of rabphilin-3A, deubiquitylates rabphilin-3A and regulates arginine vasopressin secretion in PC12 cells. Endocr. J. 65, 325\u2013334 (2018).","journal-title":"Endocr. J."},{"key":"8552_CR52","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/path.5046","volume":"244","author":"Y Yasuda","year":"2018","unstructured":"Yasuda, Y. et al. Critical role of rabphilin-3A in the pathophysiology of experimental lymphocytic neurohypophysitis. J. Pathol. 244, 469\u2013478 (2018).","journal-title":"J. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08552-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08552-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08552-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:28:22Z","timestamp":1669336102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08552-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,15]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8552"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-08552-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,15]]},"assertion":[{"value":"16 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4440"}}